Valuation, page-41

those who sold in the recent dip, have given away imo, what could be the next market darling.
All types of cancer treatments, but being able to image and early detect, reaches multiple verticals.

Heading back to IPO pricing ? getting closer to pivotal catalyst.

I recall the days when oil companies would drill for oil, and the anticipation of the find, would see a massive re-rate even before they hit their target depth.

How far will IBX re-rate even before the first tests are done ?

If the sell off from the IPO represented the impatient not hanging around, maybe its now within sight, for the herd to return.